Anadys Pharmaceuticals Inc. (Nasdaq: ANDS) agreed to be acquired by Roche for a premium of approximately $230 million in cash. The stock price more than doubled by leaping $2.61 to $3.65.
Roche To Purchase Anadys Pharmaceuticals
October 17, 2011 at 14:29 PM EDT
